The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome is a research paper published in Journal of Clinical Sleep Medicine (2023). On theSindex it has a DataRank of 0.678. It has been cited 12 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0.293
From 9 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
NICHD NIH HHS
Grant: R21 HD109777
NHLBI NIH HHS
Grant: R33 HL151254
FWCI
1.84
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals